MG
WST icon

Marex Group’s West Pharmaceutical WST Stock Holding History

Marex Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,407
Closed -$603K – 1358
2026
Q1 		$603K Buy
2,407
+900
+60% +$224K ﹤0.01% 575
2025
Q4 		$415K Buy
+1,507
New +$412K ﹤0.01% 618
2025
Q1 		– Sell
-2,850
Closed -$934K – 870
2024
Q4 		$934K Buy
2,850
+705
+33% +$222K 0.02% 252
2024
Q3 		$644K Buy
2,145
+841
+64% +$258K 0.01% 267
2024
Q2 		$430K Buy
+1,304
New +$461K 0.01% 331

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Marex Group's WST Position: Q2 2026 in Review

Marex Group sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 2,407 shares — an estimated $603K sold.

Marex Group first reported a position in WST in Q2 2024 and held it in 5 quarters. The position peaked at $934K in Q4 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Marex Group reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 2,407 West Pharmaceutical shares in Q2 2026, an estimated $603K.
  • Marex Group first reported a position in West Pharmaceutical in Q2 2024 and held it in 5 quarters.
  • Marex Group's West Pharmaceutical position peaked at $934K in Q4 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.